Eurepa MF 1 mg Tablet (10 Tab)

About Eurepa MF 1 mg Tablet:

Eurepa MF 1 mg Tablet is a combination of two anti-diabetic medications, used to treat type 2 diabetes mellitus.

Each film coated Eurepa MF 1 mg tablet contains Repaglinide 1 mg and Metformin Hydrochloride 500 mg.

Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Repaglinide is a short-acting meglitinide analogue, which lowers blood glucose by blocking ATP-dependent K channels in the ß-cell membrane resulting in depolarization. This leads to the opening of Ca channels. The resulting Ca influx stimulates the release of insulin from the pancreatic ß-cells.

Use of Eurepa MF 1 mg Tablet:

Eurepa MF 1 mg tablet is prescribed for the treatment of patients with type 2 diabetes mellitus. It helps to control high blood glucose levels.

Usage direction of Eurepa MF 1 mg Tablet:

• Eurepa MF 1 mg tablet should be taken orally.
• Eurepa MF 1 mg tablet is taken whole with the help of water.
• Do not crush, chew or break the tablet.
• Do not stop or skip the medicine without physician’s advice.
• Do not consume more than the prescribed quantity.

Precaution & Related information of Eurepa MF 1 mg Tablet:

• It is dangerous to take this preparation except under medical supervision.
• If allergic to this medicine, inform the physician immediately.
• If find any other complication inform the physician immediately.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.

Storage condition of Eurepa MF 1 mg Tablet:

Store at a temperature not exceeding 30ºC. Protected from moisture.